MB076 is an innovative heterocyclic triazole designed with enhanced plasma stability. It effectively inhibits seven distinct Class C Acinetobacter-derived cephalosporinases (ADCs) beta-lactamase variants with K i values less than 1 µM. Additionally, MB076 demonstrates a synergistic effect when combined with various cephalosporins to restore pBCSK(-) susceptibility [1].
Molekulargewicht:
373.18
CAS Nummer:
[2832966-95-5]
Formel:
C9H12BN7O5S2
Target-Kategorie:
Others
T86864
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
